'- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system - Findings underline importance of cancer evolution, and could help...
Sarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on the NHS to sarcoma patients...
Researchers at Queen’s University Belfast have received the first scientific research grant from MDS UK to improve treatment for Myelodysplastic Syndromes (MDS), a type of...
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy was more effective than a...
The inaugural London Global Cancer Week will launch at the Royal Society of Medicine on Monday 25 November. The week-long series of discussions and events...
· First clinical study to show link between types of gut bacteria and radiotherapy-induced gut damage · Studying patients’ bacterial fingerprint could help predict, prevent...
New Iridium compounds effective towards killing cancer cells even without the presence of oxygen – expanding the range of tumours that can be targeted When...